As is the case with many emerging technologies, we’re now in the early stages of defining consensus and understanding around what digital therapeutics (DTx) are and how they work.
For Pharmas to realize the full potential digital therapeutics, they need to take a much more comprehensive view of conditions and problems that HCPs and people suffering from disease and chronic conditions face.
Download the Report to learn more about: